Spots Global Cancer Trial Database for A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Official Title: A Randomized, Controlled Multicenter Trial of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Study ID: NCT01002092
Conditions
Study Description
Brief Summary: Purpose: This study will assess the safety and efficacy of Endostar combined with chemotherapy in osteosarcoma patients.
Detailed Description:
Keywords
Eligibility
Minimum Age: 12 Years
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu, China
General Hospital of Jinan Military Command, Jinan, Shandong, China
Xijing Hospital, Xi'an, Shanxi, China
The Military General Hospital of Beijing PLA, Beijing, , China
Contact Details
Name: Sujia Wu, Dr.
Affiliation: Nanjing PLA General Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Xin Shi, Dr.
Affiliation: Nanjing PLA General Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
